J Korean Med Sci.
2023 Apr;38(16):e113. 10.3346/jkms.2023.38.e113.
Current Status of Diagnosis and Treatment of Irritable Bowel Syndrome in Korea
- Affiliations
-
- 1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- KMID: 2541747
- DOI: http://doi.org/10.3346/jkms.2023.38.e113
Reference
-
1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10(7):712–21.e4. PMID: 22426087.2. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5(10):908–917. PMID: 32702295.3. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016; 150(6):S0016-5085(16)00222-5.4. Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, et al. Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition. J Neurogastroenterol Motil. 2018; 24(2):197–215. PMID: 29605976.5. Koo HS, Son HC, Lee HS, Goong HJ, Kim JS, Kim KB, et al. Survey-based analysis of the clinical treatment status of irritable bowel syndrome in Korea. J Korean Med Sci. 2023; (16):e126.
